Lerimont-L Kid Oral Suspension Strawberry is a pediatric formulation combining Levocetirizine (2.5 mg) and Montelukast (4 mg) designed for the management of allergic conditions in children. Levocetirizine, a third-generation non-sedating antihistamine, selectively antagonizes peripheral H1 receptors, effectively reducing symptoms such as rhinorrhea, sneezing, nasal congestion, and pruritus associated with allergic rhinitis and chronic urticaria. Montelukast, a leukotriene receptor antagonist, inhibits the cysteinyl leukotriene D4 receptor, thereby decreasing airway inflammation, bronchoconstriction, and mucus production, which are common in asthma and allergic rhinitis. The synergistic action of these agents provides comprehensive relief from allergic symptoms and helps improve respiratory function. The strawberry-flavored oral suspension ensures palatability and ease of administration for pediatric patients, enhancing compliance. Lerimont-L Kid is indicated for children requiring combined antihistaminic and leukotriene receptor antagonist therapy, particularly in cases of persistent allergic rhinitis and asthma prophylaxis. Dosage and duration should be determined by a healthcare professional based on the child’s age, weight, and clinical condition. Caution is advised in patients with hepatic or renal impairment, and potential side effects include headache, somnolence, and gastrointestinal disturbances.